Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
UCB
Manufacturing
Belgium's UCB hit with FDA Form 483 after April inspection
UCB Pharma has been slapped with a Form 483 from the FDA following an inspection that uncovered multiple issues.
Joseph Keenan
May 30, 2023 9:40am
Novartis targets new fields—and CAR-T—for immunology growth
May 10, 2023 5:00pm
Kansas company sues Amgen for alleged infringement with Evenity
Apr 25, 2023 2:46pm
UCB's second shot at Neupro patent validation fails on appeal
Apr 13, 2023 11:51am
Novartis, UCB set to battle it out in inflammatory skin disease
Apr 10, 2023 4:40pm
UCB touts new data for bimekizumab in hidradenitis suppurativa
Mar 20, 2023 3:05pm